Education
About Us
Working with TipRanks
Follow Us
enVVeno Medical (NVNO)
NASDAQ:NVNO
NVNO Stock Chart & Stats
Day’s Range― - ―
52-Week Range$2.03 - $5.92
Previous CloseN/A
Volume33.14K
Average Volume (3M)151.41K
Market Cap
$87.15M
Enterprise Value$70.38M
Total Cash (Recent Filing)$38.94M
Total Debt (Recent Filing)$979.00K
Price to Earnings (P/E)―
Beta1.25
Next Earnings
Jul 31, 2025EPS Estimate
-0.28Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.22
Shares Outstanding17,535,948
10 Day Avg. Volume169,638
30 Day Avg. Volume151,408
Financial Highlights & Ratios
PEG Ratio-0.03
Price to Book (P/B)2.23
Price to Sales (P/S)0.00
P/FCF Ratio-4.25
Enterprise Value/Market Cap0.81
Enterprise Value/Revenue21.51
Enterprise Value/Gross Profit499.13
Enterprise Value/Ebitda-0.77
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
enVVeno Medical News
PremiumCompany Announcements
enVVeno Medical Appoints New Chief Financial Officer
Options Prices
Currently, No data available
---
Ownership Overview
2.64% Insiders
4.33% Mutual Funds
0.23% Other Institutional Investors
88.88% Public Companies and
Individual Investors
NVNO FAQ
What was enVVeno Medical’s price range in the past 12 months?
enVVeno Medical lowest stock price was $2.03 and its highest was $5.92 in the past 12 months.
What is enVVeno Medical’s market cap?
enVVeno Medical’s market cap is $87.15M.
When is enVVeno Medical’s upcoming earnings report date?
enVVeno Medical’s upcoming earnings report date is Jul 31, 2025 which is in 9 days.
How were enVVeno Medical’s earnings last quarter?
Currently, no data Available
Is enVVeno Medical overvalued?
According to Wall Street analysts enVVeno Medical’s price is currently Overvalued.
Does enVVeno Medical pay dividends?
enVVeno Medical does not currently pay dividends.
What is enVVeno Medical’s EPS estimate?
enVVeno Medical’s EPS estimate is -0.28.
How many shares outstanding does enVVeno Medical have?
enVVeno Medical has 17,535,948 shares outstanding.
What happened to enVVeno Medical’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of enVVeno Medical?
Currently, no hedge funds are holding shares in NVNO
enVVeno Medical Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
NVNO Sentiment 100%
Sector Average 72%
Sector Average 72%
Hedge Fund Trend
Decreased
By 694.3K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.1%
Last 30 Days ▼ 6.9%
Last 30 Days ▼ 6.9%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-12.01%
12-Months-Change
Fundamentals
Return on Equity
-52.88%
Trailing 12-Months
Asset Growth
-9.48%
Trailing 12-Months
Company Description
enVVeno Medical
enVVeno Medical Corporation, a medical device company, focuses on the development of various bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous diseases. The company's lead product is the VenoValve, a surgical implant being developed for the treatment of severe deep venous chronic venous insufficiency. Its VenoValve is implanted in the femoral vein and acts as a one-way valve to help restore proper blood flow in the leg. The company was formerly known as Hancock Jaffe Laboratories, Inc. and changed its name to enVVeno Medical Corporation in October 2021. enVVeno Medical Corporation was incorporated in 1999 and is based in Irvine, California.